Condition 1: overactive bladder. Condition 2: glaucoma. Bladder contracted Glaucoma secondary to drugs
Conditions
Interventions
Intervention 1: Intervention group: Solifenacin Succinate, Tab. 5 mg Oral, daily for 4 weeks. Intervention 2: Control group: Placebo(glucose), Tab. 1 Number Oral, daily for 4 weeks.
Treatment - Drugs
Placebo
Intervention group: Solifenacin Succinate, Tab. 5 mg Oral, daily for 4 weeks
Control group: Placebo(glucose), Tab. 1 Number Oral, daily for 4 weeks
Sponsors
Vice chancellor for research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: All women with narrow-angle glaucoma and symptoms of over active bladder (urinary frequency; and urinary urgency). Exclusion criteria: A history of ocular surgery; Diabetes; Severe refractive disorders; Malignant glaucoma; A history of sensitivity to anticholinergic; Symptoms of urinary obstruction; Severe prolapse of pelvic floor.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in intraocular pressure. Timepoint: At baseline and one week and four weeks after the beginning of the study. Method of measurement: Goldman applanation tonometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change the angle of the anterior chamber of the eye. Timepoint: At baseline and one week and four weeks after the begin. Method of measurement: Gonioscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajjad Ghaffari
Emam Reza educational-medical center
Outcome results
None listed